...
首页> 外文期刊>Clinical Infectious Diseases >Moraxella catarrhalis, a Human Respiratory Tract Pathogen
【24h】

Moraxella catarrhalis, a Human Respiratory Tract Pathogen

机译:卡他莫拉菌,一种人类呼吸道病原体

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Moraxella catarrhalis is an exclusively human pathogen and is a common cause of otitis media in infants and children, causing 15%-20% of acute otitis media episodes. M. catarrhalis causes an estimated 2–4 million exacerbations of chronic obstructive pulmonary disease in adults annually in the United States. M. catarrhalis resembles commensal Neisseria species in culture and, thus, may be overlooked in samples from the human respiratory tract. The prevalence of colonization of the upper respiratory tract is high in infants and children but decreases substantially in adulthood. Most strains produce β-lactamase and are thus resistant to ampicillin but susceptible to several classes of oral antimicrobial agents. Recent work has elucidated mechanisms of pathogenesis and focused on vaccine development to prevent otitis media in children and respiratory tract infections caused by M. catarrhalis in adults with chronic obstructive pulmonary disease.
机译:卡他莫拉菌是人类的唯一病原体,是婴儿和儿童中耳炎的常见病因,引起15%-20%的急性中耳炎发作。在美国,粘膜炎莫拉氏菌每年导致成年人慢性阻塞性肺疾病加重2-4百万。卡他氏菌类似于培养中的共生奈瑟氏球菌,因此在人类呼吸道的样本中可能被忽略。婴儿和儿童的上呼吸道定植率很高,成年后则大大降低。大多数菌株产生β-内酰胺酶,因此对氨苄西林具有抗性,但对几种口服抗菌剂敏感。最近的工作阐明了发病机理,并致力于预防儿童中耳炎和成人慢性阻塞性肺疾病由卡他氏菌引起的呼吸道感染的疫苗开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号